| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/17/2008 | CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/17/2008 | CA2240394C Ob protein receptor and related compositions and methods |
| 06/17/2008 | CA2235468C Chaperone expression plasmids |
| 06/17/2008 | CA2230655C Chromatographic purification of adenovirus and aav |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/17/2008 | CA2183888C Antibody purification |
| 06/17/2008 | CA2117193C Vaccine comprising part of constant region of ige for treatment of ige-medicated allergic reactions |
| 06/17/2008 | CA2107463C Totipotent hematopoietic stem cell receptors and their ligands |
| 06/17/2008 | CA2067250C Inhibition of padgem-mediated cell binding |
| 06/17/2008 | CA2037349C Branch migration of nucleotides |
| 06/17/2008 | CA1341575C Tumor necrosis factor (tnf) inhibitory protein and its purification |
| 06/17/2008 | CA1341574C Plasmid for production of membrane protein, bacterium containing same, monoclonal antibody therefore, and method for the idenification of haemophilus influenzae |
| 06/15/2008 | CA2610862A1 Method for the production of cladribine |
| 06/12/2008 | WO2008085797A2 miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 06/12/2008 | WO2008070816A2 Staphylococcal two helix binding protein |
| 06/12/2008 | WO2008070579A2 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 06/12/2008 | WO2008070448A2 Cancer-specific promoters |
| 06/12/2008 | WO2008070370A2 Oligonucleotides for use in allele-specific pcr |
| 06/12/2008 | WO2008070367A2 Mammalian cell-based immunoglobulin display libraries |
| 06/12/2008 | WO2008070325A2 Genetic variations associated with tumors |
| 06/12/2008 | WO2008070274A2 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 06/12/2008 | WO2008070258A2 Directed differentiation of human embryonic stem cells into mesenchymal/stromal cells |
| 06/12/2008 | WO2008069992A2 Method and kit for intracellular delivery |
| 06/12/2008 | WO2008069942A2 Novel methods of enhancing delivery of a gene therapy vector using steroids |
| 06/12/2008 | WO2008069878A2 Modulating lignin in plants |
| 06/12/2008 | WO2008069747A2 Woody plants having improved growth characteristics and method for making the same |
| 06/12/2008 | WO2008069745A1 Woody plants having improved fiber characteristics and method for making the same |
| 06/12/2008 | WO2008069671A1 Transcription factor for killer cell activation, differentiation and uses thereof |
| 06/12/2008 | WO2008069598A1 Method for preparing antigen of hepatitis a virus using transformed insect cells |
| 06/12/2008 | WO2008069557A1 Method for screening inhibitors and activators of type iii secretion machinery in gram-negative bacteria |
| 06/12/2008 | WO2008069497A1 Stress specific promoters |
| 06/12/2008 | WO2008069496A1 Stress resistant plant introduced by stress - induced promoter and the gene encoding zeaxanthin epoxidase |
| 06/12/2008 | WO2008069342A1 Probe for determination of allergenicity or anti-allergenicity |
| 06/12/2008 | WO2008069318A1 Boron-tolerant plant produced by providing excess boron tolerance to plant, method for production of the plant, and gene for use in the production |
| 06/12/2008 | WO2008069290A1 Anti-hiv drug comprising fusion protein containing multimeric actinohivin, polypeptide constituting the same, gene encoding the polypeptide and method for producing the anti-hiv drug |
| 06/12/2008 | WO2008069288A1 Method of determining the haplotype of multiple allelic genes |
| 06/12/2008 | WO2008069232A1 Molecular module |
| 06/12/2008 | WO2008069122A1 Marker for differentiation of mesenchymal stem cell into chondrocyte |
| 06/12/2008 | WO2008069020A1 Method for improving solubility of protein, method for stabilizing dissolved state of protein-containing aqueous solution, and composition |
| 06/12/2008 | WO2008068982A1 Adjuvant for gene transfer comprising cell migration peptide as the active ingredient and gene transfer method using the adjuvant for gene transfer |
| 06/12/2008 | WO2008068945A1 Gene transfer aid comprising peptide capable of migrating into cell as active ingredient, and gene transfer method utilizing the gene transfer aid |
| 06/12/2008 | WO2008068906A1 Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma |
| 06/12/2008 | WO2008068827A1 Kidney-specific novel organic ion transporter |
| 06/12/2008 | WO2008068661A1 Compositions and methods for the treatment of viral hepatitis |
| 06/12/2008 | WO2008068638A2 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
| 06/12/2008 | WO2008068498A2 Regulation of plant metabolism |
| 06/12/2008 | WO2008068302A1 Reporter constructs and assays based on the human rer1 promoter |
| 06/12/2008 | WO2008068284A1 Novel oliginucleotides and use of oliginucleotides interacting with the gene coding for tyrosinase related protein-1 (trp-1) in order to modulate its expression as depigmenting agents |
| 06/12/2008 | WO2008068047A1 Micro rna targeting ets1 |
| 06/12/2008 | WO2008068046A1 Micro rna targeting aml1 |
| 06/12/2008 | WO2008068024A2 Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
| 06/12/2008 | WO2008067995A2 Means and method for raising improved immune response |
| 06/12/2008 | WO2008067841A1 Plants having improved fiber characteristics and method for making the same |
| 06/12/2008 | WO2008067840A1 Plants having improved growth characteristics and method for making the same |
| 06/12/2008 | WO2008067825A1 Hoogsteen-type triplex formation of pyrene labelled probes for nucleic acid detection in fluorescence assay |
| 06/12/2008 | WO2008067759A1 Method for modifying insect resistance of plants by utilizing rnai technique |
| 06/12/2008 | WO2008067591A1 Protein particles |
| 06/12/2008 | WO2008047134A3 Antibody molecules which bind il-17a and il-17f |
| 06/12/2008 | WO2008044150A3 Improvement of the kernel productivity of plants through the modulation of glutamine synthetase activity |
| 06/12/2008 | WO2008040787A3 Processes for producing polyunsaturated fatty acids in transgenic organisms |
| 06/12/2008 | WO2008040717A3 High yield production of sialic acid (neu5ac) by fermentation |
| 06/12/2008 | WO2008031854A3 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 06/12/2008 | WO2008020596A3 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 06/12/2008 | WO2008018909A3 Laser energy calibration based on optical measurement |
| 06/12/2008 | WO2008008224A3 Sour taste receptor compositions and methods |
| 06/12/2008 | WO2007147827A3 Production of pravastatin |
| 06/12/2008 | WO2007146511A3 Compounds and methods for modulating gene expression |
| 06/12/2008 | WO2007134234A8 Methods and compositions for obtaining marker-free transgenic plants |
| 06/12/2008 | WO2007117258A3 Growth of wild-type hepatitis a virus in cell culture |
| 06/12/2008 | WO2007107304A3 An efficient method for loading amphoteric liposomes with nucleic acid active substances |
| 06/12/2008 | WO2007103490A3 System for the expression of orthogonal translation components in eubacterial host cells |
| 06/12/2008 | WO2007087370A3 Tat-038 and methods of assessing and treating cancer |
| 06/12/2008 | WO2007084228A3 Methods for phototransfecting nucleic acid into live cells |
| 06/12/2008 | WO2007075592A3 Materials and methods for treating chronic fibrotic disease |
| 06/12/2008 | WO2007057781A8 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof. |
| 06/12/2008 | WO2007055823A3 Gpcr expressing cell lines and antibodies |
| 06/12/2008 | US20080141392 Genetic Constructs Having Heterologous 3' Polyadenylation Signal Sequence Motifs that Function in Plants |
| 06/12/2008 | US20080141390 Nucleic acid construct comprising promoter and terminator sequence coupled to permit transcription; transgenic corn |
| 06/12/2008 | US20080141389 Transgenic cell transformed with polynucleotide to increase drought tolerance |
| 06/12/2008 | US20080141388 Cell-Cycle Stress-Related Proteins and Methods of Use in Plants |
| 06/12/2008 | US20080141387 Protein Production |
| 06/12/2008 | US20080141386 Chromosomal Loci For The Stringent Control Of Gene Activities Via Transcription Activation Systems |
| 06/12/2008 | US20080141385 Determining if compound is activator or inhibitor of oxidative stress response by detecting expression of transgene in nematode; screening for antioxidants |
| 06/12/2008 | US20080141384 Composition For Screening Anti-Hypertension Drug Comprising Mammal Tctp Gene or Its Protein Product, and Method For Screening Anti-Hypertension Drug Using Said Composition |
| 06/12/2008 | US20080139800 Process For the Concentration and/or Isolation of Nucleic Acid or Nucleic Acid-Containing Species |
| 06/12/2008 | US20080139799 Sense and antisense region of given nucleotide sequences; gene silencing |
| 06/12/2008 | US20080139798 siRNA targeting myeloid cell leukemia sequence 1 |
| 06/12/2008 | US20080139791 Non-antibody protein comprising domain having immunoglobulin-like fold, capable of binding to any compound; scaffold derived from fibronectin; optimal stability and solubility |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139596 Modulators of Hcv Replication |
| 06/12/2008 | US20080139494 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 06/12/2008 | US20080139492 Nucleobase oligomeric compositions useful in enhancing RNA interference in a wide variety of cell types for treatment of virtually any disease or disorder related to overexpression of a gene or genes, as well as methods of identifying and using such compositions |
| 06/12/2008 | US20080139477 Introduced DNA sequences are replicated, stably retained and segregated independent of continuous selection pressure |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139475 Inhibition of atf2 activity to treat cancer |
| 06/12/2008 | US20080139471 Compositions and methods to prevent cancer with cupredoxins |
| 06/12/2008 | US20080139467 Method and Products For the Selective Degradation of Proteins |
| 06/12/2008 | US20080139466 Dna Sequence and Expressed Recombinant Glycoproteins Related to Feline Thyrotropin |
| 06/12/2008 | US20080139464 Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof |
| 06/12/2008 | US20080139408 Nucleic acid amplifier and method of nucleic acid amplification |